VT News

James Hartshorn

Ask VT AI
View News Summary
  • Fox Corp reports strong Q1 results, announces $1.5B buyback, but free cash flow turns negative.
  • BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Fox Corp reports strong Q1 results, announces $1.5B buyback, but free cash flow turns negative.
  • BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from James Hartshorn

Top Topics

Trending in U.S.

World

Sport